Update on improving tick-borne disease therapy from Dr Petersen.
Latest News
CHF Grant 02322 Update End-Year 3: Analysis of the Health, Behavioral, and Longevity Data Collected in the 9/11 Medical Surveillance Longitudinal Study
Update on 9/11 Surveillance Study from Dr Otto.
Research Update CHF Grant 02317 Update End-Year 3: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Update on treatment of B-cell lymphoma from Dr Breen.
Grant 02309-T Update End Year 3: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Research Update Mid-Year 1 CHF 02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma
Update on clinical trial for hemangiosarcoma treatment from Dr. Dickerson.
Research Update MAF D18CA-070 Investigating Cancers and Exposure to Environmental Chemicals
Research Update from Dr. Trepanier looking at environmental chemical exposure and cancer.
MAF Research Update – Training Pathologists to Support the Golden Retriever Lifetime Study
Update for research to train pathologists to support Golden Retriever Lifetime Study.
Research Update Mid-Year 2 CHF 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes
Research update from Dr. Volk on prognostic markers for canine mammary cancer.
Research Update FINAL CHF 02441: Evaluation of a New Vaccine for Canine Brucellosis
FINAL update from Dr. Arenas indicating a potential vaccine for canine brucellosis has been developed and tested in the laboratory on blood samples. The next step to get this vaccine to market would be to test on actual live dogs.
Research Update Mid-year 2 CHF 02428: Identifying the Disease-Defining Autoantibodies in Canine Addison’s Disease
During the initial 1.5 years of this project, we focused our efforts on sample collection across our three target breeds (Standard Poodles, Portuguese Water Dogs, English Cocker Spaniels). We have collected nearly all the required samples from Standard Poodles and Portuguese Water Dogs. Currently, we are focusing our efforts on increasing the number of English Cocker Spaniels we have enrolled in the study. We are also actively recruiting newly diagnosed patients across all three breeds through many online resources.
